LEAST BIASED
These sources have minimal bias and use very few loaded words (wording that attempts to influence an audience by appeals to emotion or stereotypes). The reporting is factual and usually sourced. These are the most credible media sources. See all Least Biased sources.
- Overall, we rate BioPharmaDive as least biased based on minimal editorializing of information. We also rate them high for factual reporting due to proper sourcing and a clean fact-check record.
Detailed Report
Bias Rating: LEAST BIASED (1.5)
Factual Reporting: HIGH (1.0)
Country: USA
MBFC’s Country Freedom Rating: MOSTLY FREE
Media Type: Website
Traffic/Popularity: Minimal Traffic
MBFC Credibility Rating: HIGH CREDIBILITY
History
Founded by Sean Griffey, Eli Dickinson, and Ryan Willumson, BioPharmaDive is an online news platform that focuses on the biotech and pharmaceutical industry and is operated by Industry Dive, based in Washington, DC. According to its about page, “BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma.”
Read our profile on the United States media and government.
Funded by / Ownership
Industry Dive, now a subsidiary of Informa Tech—a London-based British group specializing in publishing, business intelligence, and exhibitions—was acquired by Informa PLC and operates BioPharmaDive along with other verticals like FoodDive, BioPharmaDive, BioPharmaDive, CFODive, and CybersecurityDive. BioPharmaDive generates revenue from ads and sponsored content.
Read our profile on UK media and government.
Analysis/Bias
BioPharmaDive publishes news and information related to the Biotech and Pharmaceutical industry. Articles and headlines are minimally biased in word choices, such as this Bayer ends large blood thinner trial for ‘inferior efficacy’. This story, like all others reviewed, is properly sourced from credible media and information outlets.
Editorially, they do not produce op-eds; however, they do report on political issues related to the industry, like this In address to Congress, Biden touts drug pricing law and pushes insulin cost caps. In reviewing dozens, most articles are pro-business in nature. In general, all content is factual and low-biased.
Failed Fact Checks
- None in the Last 5 years
Overall, we rate BioPharmaDive as least biased based on minimal editorializing of information. We also rate them high for factual reporting due to proper sourcing and a clean fact-check record. (D. Van Zandt 11/28/2023) Updated (09/22/2025)
Source: https://www.biopharmadive.com/
Last Updated on September 22, 2025 by Media Bias Fact Check
Do you appreciate our work? Please consider one of the following ways to sustain us.
or
Left vs. Right Bias: How we rate the bias of media sources